abstract |
Compounds having the formula (I), or stereoisomers or pharmaceutically acceptable salts thereof, are useful as kinase modulators, including IRAK-4 inhibition. (I) Wherein R 2 is a monocyclic heteroaryl group and R 1 , R 3 , R 4 , R 5 and R 6 are as defined herein. |